Re-Examination of the Exacerbating Effect of Inflammasome Components during Radiation Injury
Zhongrui Li(China Pharmaceutical University), Thompson M.A(University of North Carolina at Chapel Hill), Kouros Owzar(Duke University), Brickey W.J(University of North Carolina at Chapel Hill), Ting J.P.Y(University of North Carolina at Chapel Hill), Sheng Zhang(Zhejiang Provincial People's Hospital)
Cited by 1
Related Papers
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
|Journal of Clinical Oncology|2008|655